Lisanti Capital Growth, LLC Apellis Pharmaceuticals, Inc. Transaction History

Lisanti Capital Growth, LLC

$384 Million
Q2 2024

A detailed history of Lisanti Capital Growth, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 24,885 shares of APLS stock, worth $733,360. This represents 0.25% of its overall portfolio holdings.

Number of Shares

24,885

Previous 89,210 72.11%

Holding current value

$733,360

Previous $5.24 Million 81.8%

% of portfolio

0.25%

Previous 1.38%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$38.07 - $59.71 $2.45 Million - $3.84 Million	-64,325 Reduced 72.11%	24,885 $954,000
Q1 2024 May 06, 2024	BUY	$55.39 - $72.47 $2.38 Million - $3.11 Million	42,905 Added 92.66%	89,210 $5.24 Million
Q4 2023 Feb 06, 2024	SELL	$37.14 - $64.82 $2.4 Million - $4.19 Million	-64,695 Reduced 58.28%	46,305 $2.77 Million
Q3 2023 Nov 02, 2023	BUY	$23.65 - $89.22 $1.55 Million - $5.84 Million	65,505 Added 143.98%	111,000 $4.22 Million
Q2 2023 Aug 11, 2023	SELL	$76.68 - $93.31 $3.07 Million - $3.73 Million	-40,015 Reduced 46.8%	45,495 $4.14 Million
Q1 2023 May 05, 2023	BUY	$46.59 - $66.96 $1.39 Million - $2 Million	29,815 Added 53.53%	85,510 $5.64 Million
Q4 2022 Feb 03, 2023	SELL	$43.24 - $61.04 $6.12 Million - $8.64 Million	-141,595 Reduced 71.77%	55,695 $2.88 Million
Q3 2022 Nov 01, 2022	BUY	$44.76 - $69.66 $3.03 Million - $4.72 Million	67,782 Added 52.34%	197,290 $13.5 Million
Q2 2022 Aug 03, 2022	BUY	$35.07 - $59.21 $2.79 Million - $4.71 Million	79,468 Added 158.81%	129,508 $5.86 Million
Q1 2022 May 12, 2022	SELL	$35.46 - $54.12 $1.89 Million - $2.89 Million	-53,385 Reduced 51.62%	50,040 $2.54 Million
Q4 2021 Feb 04, 2022	BUY	$30.74 - $49.16 $3.18 Million - $5.08 Million	103,425 New	103,425 $4.89 Million
Q3 2021 Nov 03, 2021	SELL	$31.4 - $69.84 $3.75 Million - $8.34 Million	-119,445 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $4.89 Million - $7.75 Million	119,445 New	119,445 $7.55 Million
Q1 2021 May 12, 2021	SELL	$40.8 - $57.39 $5.51 Million - $7.74 Million	-134,945 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$30.79 - $57.2 $4.15 Million - $7.72 Million	134,945 New	134,945 $7.72 Million
Q2 2020 Aug 10, 2020	SELL	$24.8 - $38.49 $703,080 - $1.09 Million	-28,350 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$17.91 - $44.33 $507,748 - $1.26 Million	28,350 New	28,350 $759,000

Others Institutions Holding APLS

# of Institutions

299

Shares Held

113M

Call Options Held

5.21M

Put Options Held

691K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.24B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Account

Lisanti Capital Growth, LLC Apellis Pharmaceuticals, Inc. Transaction History